Cyclodextrin (CD)-based
host–guest interactions with adamantane
(Ad) have demonstrated use for functionalizing living cells
in vitro
. The next step in this supramolecular functionalization
approach is to explore the concept to deliver chemical cargo to living
cells
in vivo
, e.g., inoculated bacteria, in order
to study their dissemination. We validated this concept in two rodent
Staphylococcus aureus
models. Bacteria (1 × 10
8
viable
S. aureus
) were inoculated by (1)
intramuscular injection or (2) intrasplenic injection followed by
dissemination throughout the liver. The bacteria were prefunctionalized
with
99m
Tc-UBI
29–41
-Ad
2
(primary
vector), which allowed us to both determine the bacterial load and
create an
in vivo
target for the secondary host-vector
(24 h post-inoculation). The secondary vector, i.e., chemical cargo
delivery system, made use of a
111
In-Cy5
0.5
CD
9
PIBMA
39
polymer that was administered intravenously.
Bacteria-specific cargo delivery as a result of vector complexation
was evaluated by dual-isotope SPECT imaging and biodistribution studies
(
111
In), and by fluorescence (Cy5); these evaluations were
performed 4 h post-injection of the secondary vector. Mice inoculated
with nonfunctionalized
S. aureus
and mice without
an infection served as controls. Dual-isotope SPECT imaging demonstrated
that
111
In-Cy5
0.5
CD
9
PIBMA
39
colocalized with
99m
Tc-UBI
29–41
-Ad
2
-labeled bacteria in both muscle and liver. In inoculated
muscle, a 2-fold higher uptake level (3.2 ± 1.0%ID/g) was noted
compared to inoculation with nonfunctionalized bacteria (1.9 ±
0.4%ID/g), and a 16-fold higher uptake level compared to noninfected
muscle (0.2 ± 0.1%ID/g). The hepatic accumulation of the host-vector
was nearly 10-fold higher (27.1 ± 11.1%ID/g) compared to the
noninfected control (2.7 ± 0.3%ID/g;
p
<
0.05). Fluorescence imaging of the secondary vector corroborated SPECT-imaging
and biodistribution findings. We have demonstrated that supramolecular
host–guest complexation can be harnessed to achieve an
in vivo
cargo delivery strategy, using two different bacterial
models in soft tissue and liver. This proof-of-principle study paves
a path toward developing innovative drug delivery concepts via cell
functionalization techniques.